In-silico investigations on the anticancer activity of selected 2-aryloxazoline derivatives against breast cancer

References

• Akram, M., Iqbal, M., Daniyal, M., & Khan, A. U. (2017). Awareness and current knowledge of breast cancer. Biological Research, 50(1), 1–23. https://doi.org/10.1186/s40659-017-0140-9
   PubMedGoogle Scholar
• Ali, M. A., Nath, A., Jannat, M., & Islam, M. M. (2021). Direct synthesis of diamides from dicarboxylic acids with amines using Nb2O5 as a Lewis acid catalyst and molecular docking studies as anticancer agents. ACS Omega, 6(38), 25002–25009. https://doi.org/10.1021/acsomega.1c04069
   PubMed Web of Science ®Google Scholar
• Andl, C. D., Mizushima, T., Nakagawa, H., Oyama, K., Harada, H., Chruma, K., Herlyn, M., & Rustgi, A. K. (2003). Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. The Journal of Biological Chemistry, 278(3), 1824–1830. https://doi.org/10.1074/jbc.M209148200
   PubMed Web of Science ®Google Scholar
• Argomedo, L. M., Barroso, V. M., Barreiro, C. S., Darbem, M. P., Ishida, K., & Stefani, H. A. (2020). Novel 2-aryloxazoline compounds exhibit an inhibitory effect on Candida spp., including antifungal-resistant isolates. ACS Medicinal Chemistry Letters, 11(12), 2470–2475. https://doi.org/10.1021/acsmedchemlett.0c00449
   PubMed Web of Science ®Google Scholar
• Bansal, S., & Halve, A. (2014). Oxazolines: Their synthesis and biological activity. International Journal of Pharmaceutical Sciences and Research, 5(11), 4601.
   Google Scholar
• Celanire, S., Talaga, P., Leurs, R., Denonne, F., Timmerman, H., & Lebon, F. (2011). Compounds comprising an oxazoline or thiazoline moiety, processes for making them, and their uses. Google Patents.
   Google Scholar
• Cuyàs, E., Corominas-Faja, B., & Menendez, J. A. (2014). The nutritional phenome of EMT-induced cancer stem-like cells. Oncotarget, 5(12), 3970–3982. https://doi.org/10.18632/oncotarget.2147
   PubMedGoogle Scholar
• Daniel, A. R., Hagan, C. R., & Lange, C. A. (2011). Progesterone receptor action: Defining a role in breast cancer. Expert Review of Endocrinology & Metabolism, 6(3), 359–369. https://doi.org/10.1586/eem.11.25
   PubMedGoogle Scholar
• Dar, A. M., Khan, M., Mir, S., & Gatoo, M. (2016). DNA binding, cleavage activity, molecular docking, cytotoxicity and genotoxicity studies of newly synthesized copper based metal complexes. Pharmaceutica Analytica Acta, 7(464), 1636–1616.
   Google Scholar
• de las Mercedes Noriega, M., Paesani, F., Perazzo, F., Lago, N., Krupitzki, H., Nieto, S., Garcia, A., Avagnina, A., Elsner, B., & Denninghoff, V. C. (2012). Immunohistochemical characterization of neoplastic cells of breast origin. Diagnostic Pathology, 7(1), 1–5.
   PubMedGoogle Scholar
• Djurendic, E., Vujaskovic, S., Sakac, M., Ajdukovic, J., Gakovic, A., Kojic, V., Bogdanovic, G., Klisuric, O., Gasi, G. (2011). Synthesis and biological evaluation of some new 2-oxazoline and salicylic acid derivatives. ARKIVOC (ii), 83.
   Google Scholar
• Donepudi, M. S., Kondapalli, K., Amos, S. J., & Venkanteshan, P. (2014). Breast cancer statistics and markers. Journal of Cancer Research and Therapeutics, 10(3), 506–511. https://doi.org/10.4103/0973-1482.137927
   PubMed Web of Science ®Google Scholar
• Garg, P., Chaudhary, S., & Milton, M. D. (2014). Synthesis of 2-aryl/heteroaryloxazolines from nitriles under metal-and catalyst-Free conditions and evaluation of their antioxidant activities. The Journal of Organic Chemistry, 79(18), 8668–8677. https://doi.org/10.1021/jo501430p
   PubMed Web of Science ®Google Scholar
• Gros, C., Fahy, J., Halby, L., Dufau, I., Erdmann, A., Gregoire, J.-M., Ausseil, F., Vispé, S., & Arimondo, P. B. (2012). DNA methylation inhibitors in cancer: recent and future approaches. Biochimie, 94(11), 2280–2296. https://doi.org/10.1016/j.biochi.2012.07.025
   PubMed Web of Science ®Google Scholar
• Jayakumar, A., Chirala, S. S., Chinault, A. C., Baldini, A., Abu-Elheiga, L., & Wakil, S. J. (1994). Isolation and chromosomal mapping of genomic clones encoding the human fatty acid synthase gene. Genomics, 23(2), 420–424. https://doi.org/10.1006/geno.1994.1518
   PubMed Web of Science ®Google Scholar
• Jensen, V., Ladekarl, M., Holm‐Nielsen, P., Melsen, F., & Soerensen, F. B. (1995). The prognostic value of oncogenic antigen 519 (OA‐519) expression and proliferative activity detected by antibody MIB‐I in node‐negative breast cancer. The Journal of Pathology, 176(4), 343–352. https://doi.org/10.1002/path.1711760405
   PubMed Web of Science ®Google Scholar
• Kiani, J., Khan, A., Khawar, H., Shuaib, F., & Pervez, S. (2006). Estrogen receptor α-negative and progesterone receptor-positive breast cancer: Lab error or real entity? Pathology Oncology Research: POR, 12(4), 223–227. https://doi.org/10.1007/BF02893416
   PubMed Web of Science ®Google Scholar
• Kuhajda, F. P., Piantadosi, S., & Pasternack, G. R. (1989). Haptoglobin-related protein (Hpr) epitopes in breast cancer as a predictor of recurrence of the disease. The New England Journal of Medicine, 321(10), 636–641. https://doi.org/10.1056/NEJM198909073211003
   PubMed Web of Science ®Google Scholar
• Kuhl, H., & Schneider, H. (2013). Progesterone–promoter or inhibitor of breast cancer. Climacteric, 16(sup1), 54–68. https://doi.org/10.3109/13697137.2013.768806
   PubMed Web of Science ®Google Scholar
• Kumar, V. S., Gudise, V. B., Reddy, E. K., & Anwar, S. (2019). XtalFluor-E: An efficient reagent for synthesis of oxazolines from carboxylic acids and O-silylated amino alcohols. Journal of Heterocyclic Chemistry.
   Google Scholar
• Kumari, R., Kumar, R., Consortium, O. S. D. D., & Lynn, A, Open Source Drug Discovery Consortium (2014). g_mmpbsa – A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Laganière, J., Deblois, G., & Giguère, V. (2005). Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor α1 gene in breast cancer cells. Molecular Endocrinology (Baltimore, Md.), 19(6), 1584–1592. https://doi.org/10.1210/me.2005-0040
   PubMedGoogle Scholar
• Leeson, P. D., & Springthorpe, B. (2007). The influence of drug-like concepts on decision-making in medicinal chemistry. Nature Reviews. Drug Discovery, 6(11), 881–890. https://doi.org/10.1038/nrd2445
   PubMed Web of Science ®Google Scholar
• Li, Q., Woods, K. W., Claiborne, A., Gwaltney, S. L., Barr, K. J., Liu, G., Gehrke, L., Credo, R. B., Hui, Y. H., Lee, J., Warner, R. B., Kovar, P., Nukkala, M. A., Zielinski, N. A., Tahir, S. K., Fitzgerald, M., Kim, K. H., Marsh, K., Frost, D., … Sham, H. L. (2002). Synthesis and biological evaluation of 2-indolyloxazolines as a new class of tubulin polymerization inhibitors. Discovery of A-289099 as an orally active antitumor agent. Bioorganic & Medicinal Chemistry Letters, 12(3), 465–469. https://doi.org/10.1016/S0960-894X(01)00759-4
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23(1-3), 3–25. https://doi.org/10.1016/S0169-409X(96)00423-1
   Web of Science ®Google Scholar
• Lovering, F., Bikker, J., & Humblet, C. (2009). Escape from flatland: increasing saturation as an approach to improving clinical success. Journal of Medicinal Chemistry, 52(21), 6752–6756. https://doi.org/10.1021/jm901241e
   PubMed Web of Science ®Google Scholar
• Matsuda, K-i., Ochiai, I., Nishi, M., & Kawata, M. (2002). Colocalization and ligand-dependent discrete distribution of the estrogen receptor (ER) α and ERβ. Molecular Endocrinology (Baltimore, Md.), 16(10), 2215–2230. https://doi.org/10.1210/me.2002-0110
   PubMedGoogle Scholar
• Menendez, J. A., & Lupu, R. (2007). Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nature Reviews. Cancer, 7(10), 763–777. https://doi.org/10.1038/nrc2222
   PubMed Web of Science ®Google Scholar
• Milgraum, L. Z., Witters, L. A., Pasternack, G. R., & Kuhajda, F. P. (1997). Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 3(11), 2115–2120.
   PubMed Web of Science ®Google Scholar
• Nath, A., Kumer, A., Zaben, F., & Khan, M. W. (2021). Investigating the binding affinity, molecular dynamics, and ADMET properties of 2, 3-dihydrobenzofuran derivatives as an inhibitor of fungi, bacteria, and virus protein. Beni-Suef University Journal of Basic and Applied Sciences, 10(1), 1–13. https://doi.org/10.1186/s43088-021-00117-8
   Google Scholar
• Normanno, N., De Luca, A., Bianco, C., Strizzi, L., Mancino, M., Maiello, M. R., Carotenuto, A., De Feo, G., Caponigro, F., & Salomon, D. S. (2006). Epidermal growth factor receptor (EGFR) signaling in cancer. Gene, 366(1), 2–16. https://doi.org/10.1016/j.gene.2005.10.018
   PubMed Web of Science ®Google Scholar
• Onishi, H. R., Pelak, B. A., Gerckens, L. S., Silver, L. L., Kahan, F. M., Chen, M. H., Patchett, A. A., Galloway, S. M., Hyland, S. A., Anderson, M. S., & Raetz, C. R. (1996). Antibacterial agents that inhibit lipid A biosynthesis. Science (New York, N.Y.), 274(5289), 980–982. https://doi.org/10.1126/science.274.5289.980
   PubMed Web of Science ®Google Scholar
• Padmaja, A., Rajasekhar, C., Durgamma, S., Venkatesh, B. C., & Padmavathi, V. (2014). Synthesis and antioxidant activity of pyrazolyl-oxazolines/thiazolines and isoxazolyl-oxazolines/thiazolines. Medicinal Chemistry Research, 23(3), 1084–1098. https://doi.org/10.1007/s00044-013-0688-z
   Web of Science ®Google Scholar
• Padmavathi, V., Mahesh, K., Reddy, G. D., & Padmaja, A. (2010). Synthesis and bioassay of pyrrolyl oxazolines and thiazolines. European Journal of Medicinal Chemistry, 45(7), 3178–3183. https://doi.org/10.1016/j.ejmech.2010.04.010
   PubMed Web of Science ®Google Scholar
• Pattar, S. V., Adhoni, S. A., Kamanavalli, C. M., & Kumbar, S. S. (2020). In silico molecular docking studies and MM/GBSA analysis of coumarin-carbonodithioate hybrid derivatives divulge the anticancer potential against breast cancer. Beni-Suef University Journal of Basic and Applied Sciences, 9(1), 1–10. https://doi.org/10.1186/s43088-020-00059-7
   Google Scholar
• Sarkar, M. S. U., Nath, A., Kumer, A., Mallik, C., Akter, F., Moniruzzaman, M., & Ali, M. A. (2021). Synthesis, molecular docking screening, ADMET and dynamics studies of synthesized 4-(4-methoxyphenyl)-8-methyl-3, 4, 5, 6, 7, 8-hexahydroquinazolin-2 (1H)-one and quinazolinone derivatives. Journal of Molecular Structure, 1244, 130953. https://doi.org/10.1016/j.molstruc.2021.130953
   Web of Science ®Google Scholar
• Smith, S. (1994). The animal fatty acid synthase: one gene, one polypeptide, seven enzymes. The FASEB Journal: official Publication of the Federation of American Societies for Experimental Biology, 8(15), 1248–1259.
   PubMed Web of Science ®Google Scholar
• Stratton, C. F., Newman, D. J., & Tan, D. S. (2015). Cheminformatic comparison of approved drugs from natural product versus synthetic origins. Bioorganic & Medicinal Chemistry Letters, 25(21), 4802–4807. https://doi.org/10.1016/j.bmcl.2015.07.014
   PubMed Web of Science ®Google Scholar
• Tan, H., Zhong, Y., & Pan, Z. (2009). Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines. BMC Cancer, 9(1), 1–12. https://doi.org/10.1186/1471-2407-9-31
   PubMedGoogle Scholar
• Tsuda, M., Yamakawa, M., Oka, S., Tanaka, Y., Hoshino, Y., Mikami, Y., Sato, A., Fujiwara, H., Ohizumi, Y., & Kobayashi, J. i (2005). Brasilibactin A, a cytotoxic compound from actinomycete Nocardia brasiliensis. Journal of Natural Products, 68(3), 462–464. https://doi.org/10.1021/np0496385
   PubMed Web of Science ®Google Scholar
• Tsukamoto, M., Murooka, K., Nakajima, S., Abe, S., Suzuki, H., Hirano, K., Kondo, H., Kojiri, K., & Suda, H. (1997). BE-32030 A, B, C, D and E, new antitumor substances produced by Nocavdia sp. A32030. The Journal of Antibiotics, 50(10), 815–821. https://doi.org/10.7164/antibiotics.50.815
   PubMed Web of Science ®Google Scholar
• Tuccinardi, T. (2021). What is the current value of MM/PBSA and MM/GBSA methods in drug discovery?. Expert Opinion on Drug Discovery, 16, 1233–1237.
   Google Scholar
• van de Stolpe, A., Slycke, A. J., Reinders, M. O., Zomer, A. W., Goodenough, S., Behl, C., Seasholtz, A. F., & van der Saag, P. T. (2004). Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERα and ERβ. Molecular Endocrinology (Baltimore, Md.), 18(12), 2908–2923. https://doi.org/10.1210/me.2003-0446
   PubMedGoogle Scholar
• Vizi, E. S. (1986). Compounds acting on alpha1‐and alpha2‐adrenoceptors: Agonists and antagonists. Medicinal Research Reviews, 6(4), 431–449. https://doi.org/10.1002/med.2610060403
   PubMed Web of Science ®Google Scholar
• Wager, T. T., Hou, X., Verhoest, P. R., & Villalobos, A. (2010). Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties. ACS Chemical Neuroscience, 1(6), 435–449. https://doi.org/10.1021/cn100008c
   PubMed Web of Science ®Google Scholar
• Wang, Z.-Y., & Yin, L. (2015). Estrogen receptor alpha-36 (ER-α36): A new player in human breast cancer. Molecular and Cellular Endocrinology, 418, 193–206. https://doi.org/10.1016/j.mce.2015.04.017
   PubMed Web of Science ®Google Scholar
• Yin, P., Lin, Z., Cheng, Y.-H., Marsh, E. E., Utsunomiya, H., Ishikawa, H., Xue, Q., Reierstad, S., Innes, J., Thung, S., Kim, J. J., Xu, E., & Bulun, S. E. (2007). Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells. The Journal of Clinical Endocrinology and Metabolism, 92(11), 4459–4466. https://doi.org/10.1210/jc.2007-0725
   PubMed Web of Science ®Google Scholar